Shimano Receives US Patent for Cycling Shoes

U.S. patent for an innovative wireless electronic cleat system designed for cycling shoes.

Image credits: Shimano

The United States Patent and Trademark Office has granted Shimano a US patent for a wireless electronic cleat system for cycling shoes. As you ride, the changes the shoe's position in relation to your pedals. With the use of inputs from rider and bike sensors, it enables lateral and fore-aft positioning. These produce data that finds the ideal shoe position and moves there automatically. It is also possible to change manually.

Typically, a pedal, cleat, and shoe connect a rider to their bicycle. An "adjuster" on the sole of the shoe is present in this instance. This is equipped with the cleat, and the shoe attaches to the pedal using the conventional method. With the help of rails, this adjuster's reversible electric motor may move the shoe from front to back and left to right, reports New Atlas.

The system's primary battery is located in the pedal, and the shoe, cleat, and adjuster are all powered via a wireless system.

But why such adjustability? Because bicyclists adapt their body position to the many terrains they ride on, including varying uphill and downhill grades. This can alter the legs' pivot points and angles; if the foot's contact point can adapt to compensate, there may be mechanical benefits and improved performance.

Related Walk Faster With These Robotic Shoes

The possible performance advantages of Shimano's adjustable shoes are not yet supported by scientific data, despite their technological promise. “adjusting the anterior-posterior foot position on the pedal does not affect cycling economy in competitive cyclists pedaling at a steady-state power output eliciting approximately 90% of VT [Ventilatory Threshold],” according to a study published in 2023. The results of this study, which was probably carried out in a controlled laboratory setting, imply that the advantages of adjusting foot position may be few, or at the very least, insignificant enough to have no effect on overall performance under steady-state settings.

Sam Draper
September 4, 2024

Innovation of the Month

Do you want to discover more, visit the website
Visit Website

Other news

Tandem Plans to Submit Insulin Pump for FDA Assessment

During a time, in which Tandem is struggling from operating losses and lower-than-expected sales.

VivaLNK Partners with Emory University to Provide Wearable ECG Sensors for Study

VivaLNK, a Campbell, CA-based connected healthcare solutions provider, teamed up with....

How Wearables Like Oura and Whoop Became Pandemic Lifestyle

During quarantine, obsessive health tracking has become a hobby for people with means. Adelene...

Graphene to Protect Implantable Neurostimulators in People with Neurological Disorders

The US is seeing a rise in neurological disorders such as Alzheimer’s disease and Parkinson’ disease
Discover more